Literature DB >> 1431244

Differential antibody responses to rubella virus infection in males and females.

L A Mitchell1, T Zhang, A J Tingle.   

Abstract

Specificities of human rubella virus (RV)-specific IgG, IgM, and IgA antibodies for RV structural proteins (envelope E1 and E2 and capsid) and an E1 domain represented by a synthetic peptide (BCH-178) were determined by immunoblot and ELISA techniques in sera from rubella-infected individuals. Sequential sera were obtained from 67 females and 32 males during acute and convalescent infection phases. Males and females had differences in all antibody classes, especially during the early acute infection phase. At no time during follow-up were IgA anti-E2 antibodies detected in males, in contrast to the case in females. Significantly lower levels of IgG antibody directed to E2 were also observed in males. Males had earlier onset of E1-specific IgG and IgM antibodies with a greater proportion of total RV antibody response directed to E1 (IgG) or E1 peptide (IgM). These differences suggest there are hormonal and genetic influences on immune recognition of RV proteins that may be related to the increased incidence of rubella-associated arthropathy in females.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431244     DOI: 10.1093/infdis/166.6.1258

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  A perspective on vaccine evaluation research in Canada: Past and future.

Authors:  D W Scheifele; A J Tingle
Journal:  Can J Infect Dis       Date:  1993-03

2.  Sex differences in murine susceptibility to systemic viral infections.

Authors:  Theresa L Geurs; Elaise B Hill; Danna M Lippold; Anthony R French
Journal:  J Autoimmun       Date:  2011-12-29       Impact factor: 7.094

3.  Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.

Authors:  Neelam Dhiman; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Jenna E Ryan; Robert M Jacobson; Inna G Ovsyannikova; Gregory A Poland
Journal:  Cytokine       Date:  2010-02-01       Impact factor: 3.861

4.  Socioeconomic correlates of antibody levels to enteric pathogens among Israeli adolescents.

Authors:  T Hasin; R Dagan; G Boutboul; E Derazne; O Atias; D Cohen
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

5.  Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Neelam Dhiman; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

6.  PCR for detection of rubella virus RNA in clinical samples.

Authors:  T J Bosma; K M Corbett; S O'Shea; J E Banatvala; J M Best
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

Review 7.  Personalized vaccines: the emerging field of vaccinomics.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Expert Opin Biol Ther       Date:  2008-11       Impact factor: 4.388

8.  Borna disease virus (BDV) infection in psychiatric patients and healthy controls in Iran.

Authors:  Elham Mazaheri-Tehrani; Nader Maghsoudi; Jamal Shams; Hamid Soori; Hasti Atashi; Fereshteh Motamedi; Liv Bode; Hanns Ludwig
Journal:  Virol J       Date:  2014-09-03       Impact factor: 4.099

Review 9.  Immunoinformatics and Vaccine Development: An Overview.

Authors:  Angus Nnamdi Oli; Wilson Okechukwu Obialor; Martins Ositadimma Ifeanyichukwu; Damian Chukwu Odimegwu; Jude Nnaemeka Okoyeh; George Ogonna Emechebe; Samson Adedeji Adejumo; Gordon C Ibeanu
Journal:  Immunotargets Ther       Date:  2020-02-26

10.  Rubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy.

Authors:  Courtney S Pilkerton; Gerald R Hobbs; Christa Lilly; Sarah S Knox
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.